Published in Inflammation on April 01, 1999
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology (2004) 1.54
Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol (2003) 0.96
Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation (2001) 0.89
Nitric oxide modifies chromatin to suppress ICAM-1 expression during colonic inflammation. Am J Physiol Gastrointest Liver Physiol (2012) 0.79
Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice. J Med Food (2014) 0.75
Melatonin improves experimental colitis with sleep deprivation. Int J Mol Med (2015) 0.75
Heme Oxygenase-1 Induction and Anti-inflammatory Actions of Atractylodes macrocephala and Taraxacum herba Extracts Prevented Colitis and Was More Effective than Sulfasalazine in Preventing Relapse. Gut Liver (2017) 0.75
Assessment of cell cycle phase-specific effects of zerumbone on mitotically synchronous surface cultures of Physarum polycephalum. Protoplasma (2014) 0.75
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology (1989) 7.59
Nitric oxide synthases in mammals. Biochem J (1994) 6.50
Experimental models of inflammatory bowel disease. Gastroenterology (1995) 6.28
1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem (1997) 3.52
Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett (1991) 3.43
Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem (1995) 3.33
Greatly increased luminal nitric oxide in ulcerative colitis. Lancet (1994) 2.96
Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology (1996) 2.51
Inflammatory bowel disease. N Engl J Med (1996) 2.22
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
A comparative analysis of two models of colitis in rats. Gastroenterology (1992) 2.13
Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest (1996) 2.00
Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut (1995) 1.70
Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest (1997) 1.70
Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology (1997) 1.66
Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol (1995) 1.63
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut (1995) 1.52
The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol (1993) 1.51
Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol (1993) 1.40
Experimental colitis in animal models. Scand J Gastroenterol (1992) 1.37
Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci (1997) 1.33
The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol (1995) 1.28
Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol (1991) 1.23
Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol (1997) 1.21
Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res (1995) 1.20
Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest (1996) 1.15
Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol (1997) 1.05
Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clin Invest (1996) 0.99
Manipulation of the L-arginine-nitric oxide pathway in experimental colitis. Br J Surg (1995) 0.95
Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology (1995) 0.93
Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J Pharm Pharmacol (1995) 0.92
The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther (1997) 0.89
Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats. Arch Biochem Biophys (1995) 0.86
Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells. Br J Pharmacol (1998) 0.85
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis. Dig Dis Sci (1997) 0.85
Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid. Br J Cancer (1998) 0.84
Induction of nitric oxide synthase in rat intestine and its association with tissue injury. Agents Actions (1993) 0.83
Enhanced systemic nitric oxide production in inflammatory bowel disease. Lancet (1993) 0.83
Colonic microvascular integrity in acute endotoxaemia: interactions between constitutive nitric oxide and 5-lipoxygenase products. Eur J Pharmacol (1995) 0.81
Time-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol (1997) 0.81
Is nitric oxide and heparin treatment justified in inflammatory bowel disease? An experimental study. Scand J Clin Lab Invest (1996) 0.79
Prostaglandin E2 and gestational hypotension in rabbits. Prostaglandins (1990) 0.75
Effects of NO-donors, SIN-1 and GEA 3175 on prostacyclin and cGMP synthesis in cultured rat endothelial cells. Agents Actions Suppl (1995) 0.75
Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ (2001) 2.91
Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol (1999) 2.70
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther (2007) 2.38
Probiotics in the management of atopic eczema. Clin Exp Allergy (2000) 2.00
The causal element for the lactase persistence/non-persistence polymorphism is located in a 1 Mb region of linkage disequilibrium in Europeans. Ann Hum Genet (2003) 1.96
Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res (2002) 1.92
Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med (1990) 1.90
Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy (2005) 1.75
A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr Scand (1991) 1.74
Sevoflurane-nitrous oxide or halothane-nitrous oxide for paediatric bronchoscopy and gastroscopy. Br J Anaesth (1996) 1.68
Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microbiol (1997) 1.65
Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J Hum Nutr Diet (2006) 1.64
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther (2005) 1.64
Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol (2002) 1.62
Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD. Eur Respir J (2009) 1.54
Nutritional modulation of exercise-induced immunodepression in athletes: a systematic review and meta-analysis. Eur J Clin Nutr (2006) 1.51
Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr (1999) 1.36
Paediatric out-of-hospital cardiac arrests--epidemiology and outcome. Resuscitation (1995) 1.33
Probiotics reduce the prevalence of oral candida in the elderly--a randomized controlled trial. J Dent Res (2007) 1.30
Double-blind evaluation of a lignocaine-prilocaine cream (EMLA) in children. Effect on the pain associated with venous cannulation. Br J Anaesth (1986) 1.29
Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med (1997) 1.27
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther (2005) 1.25
Nitric oxide in inflammation and immune response. Ann Med (1995) 1.25
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension (2001) 1.23
Utstein style reporting of in-hospital paediatric cardiopulmonary resuscitation. Resuscitation (2000) 1.16
Does prophylactic intravenous infusion of indomethacin improve the management of postoperative pain in children? Can J Anaesth (1988) 1.15
Comparison of buprenorphine with morphine in the treatment of postoperative pain in children. Anesth Analg (1988) 1.14
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer (2007) 1.13
Studies on diuretic and hypouricemic effects of Orthosiphon stamineus methanol extracts in rats. J Ethnopharmacol (2008) 1.11
Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr (1994) 1.10
Delayed eosinophil apoptosis in asthma. J Allergy Clin Immunol (2000) 1.10
Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol (1993) 1.10
Studies with pinealectomized rats. Pharmacology (1970) 1.10
Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy (2008) 1.10
Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol (2003) 1.09
Measurement of pain in children with self-reporting and behavioral assessment. Clin Pharmacol Ther (1987) 1.07
Fructooligosaccharides and lactulose cause more symptoms in lactose maldigesters and subjects with pseudohypolactasia than in control lactose digesters. Am J Clin Nutr (1999) 1.07
Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain of children. Br J Anaesth (1988) 1.06
Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol (2001) 1.06
Enhanced neutrophil migration in vivo HLA B27 positive subjects. Ann Rheum Dis (1984) 1.06
Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia (2013) 1.06
Lactose intolerance. J Am Coll Nutr (2000) 1.06
Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol (1993) 1.05
Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA). Arzneimittelforschung (1975) 1.04
Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol (1988) 1.03
CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro. Eicosanoids (1988) 1.02
A combination of fibre-rich rye bread and yoghurt containing Lactobacillus GG improves bowel function in women with self-reported constipation. Eur J Clin Nutr (2006) 1.00
Lactase haplotype frequencies in Caucasians: association with the lactase persistence/non-persistence polymorphism. Ann Hum Genet (1998) 0.99
Endothelium-dependent and -independent effects of exogenous ATP, adenosine, GTP and guanosine on vascular tone and cyclic nucleotide accumulation of rat mesenteric artery. Br J Pharmacol (1992) 0.99
Combined toxicity of ethanol with chlorpromazine, diazepam, chlormethiazole or pentobarbital in mice. Agents Actions (1969) 0.99
Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. J Pharmacol Exp Ther (2001) 0.99
The role of nitric oxide in osteoarthritis. Scand J Rheumatol (2007) 0.99
Modulation of arachidonic acid metabolism by phenols: relation to their structure and antioxidant/prooxidant properties. Free Radic Biol Med (1999) 0.98
Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther (2007) 0.98
Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med (2001) 0.98
Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension (2001) 0.98
Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur J Clin Nutr (2010) 0.98
Role of irritable bowel syndrome in subjective lactose intolerance. Am J Clin Nutr (1998) 0.97
Effects of cysteine and nitroglycerin on bovine heart guanylate cyclase and on tissue cyclic GMP and lactate of rat atria. Eur J Pharmacol (1983) 0.96
Acute and long-term effects of winter swimming and whole-body cryotherapy on plasma antioxidative capacity in healthy women. Scand J Clin Lab Invest (2005) 0.96
Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia. Br J Nutr (2001) 0.95
Effects of TNFalpha-antagonists on nitric oxide production in human cartilage. Osteoarthritis Cartilage (2002) 0.94
Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J Hum Hypertens (2004) 0.94
Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. Eur J Pharmacol (1998) 0.93
Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr (2012) 0.93
Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis. Clin Rheumatol (1985) 0.93
Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis. Eur J Pharmacol (2001) 0.93
Kinetics and dynamics of postoperative intravenous morphine in children. Clin Pharmacol Ther (1988) 0.92
Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache (1998) 0.92
Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea. Br J Pharmacol (1998) 0.91
Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin. Biochem J (2001) 0.91
Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J (2001) 0.91
Cyclic amp concentration and enzyme activities of cerebrospinal fluid in patients with epilepsy or central nervous system damage. Eur Neurol (1975) 0.90
Impact of age, submersion time and water temperature on outcome in near-drowning. Resuscitation (2002) 0.90
Haemodynamic and hormonal responses to heat exposure in a Finnish sauna bath. Eur J Appl Physiol Occup Physiol (1989) 0.90
Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone. Eur J Pharmacol (2000) 0.90
Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension (1998) 0.90
Effects of mild physical exercise on serum lipoproteins and metabolites of arachidonic acid: a controlled randomised trial in middle aged men. Br Med J (Clin Res Ed) (1984) 0.90
Paediatric cardiac arrest and resuscitation provided by physician-staffed emergency care units. Acta Anaesthesiol Scand (1997) 0.90
Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acetic acid-induced colitis in rats. Scand J Gastroenterol (2001) 0.89
Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation (2001) 0.89
Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br J Pharmacol (1996) 0.89
Exogenous GTP enhances the effects of sodium nitrite on cyclic GMP accumulation, vascular smooth muscle relaxation and platelet aggregation. Pharmacol Toxicol (1991) 0.89
Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats. J Physiol Pharmacol (2009) 0.89